Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript
HRMY earnings call for the period ending September 30, 2023.
Stay updated with breaking news from Kumar Budur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HRMY earnings call for the period ending September 30, 2023.
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...
Harmony Biosciences Holdings Inc shares sank 38% to $18.66 in late-morning trading on Friday after the pharmaceutical company reported topline results from...
Treatment with pitolisant achieved robust clinical response in patients with idiopathic hypersomnia, according to phase 3 study results.
The INTUNE study of pitolisant for IH showed no statistical significance against placebo for daytime sleepiness in the withdrawal phase.